Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-21-049313

Director bought 12,000 shares at $8.57 ($102,796)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Polly A. Director 2021-12-20 Purchase +12,000 $8.57 $102,796 23,295 D
Open-market purchases · 12,000 sh · avg $8.57 · $102,796
Loading xslF345X03/doc4.xml…